U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Selection of antibody combinations

Normal or clonal B cells CD19, CD20, kappa, lambda CD19(CD20)/k, CD19(CD20)/l CD19(20)/k/l B cells of CLL vs. other lymphoproliferative disorders CD19, CD20, CD5, CD23,